Clinical Practice Guidelines of Russian Gastroenterological Association, Scientific Society for the Clinical Study of Human Microbiome, Russian Society for the Prevention of Non-Communicable Diseases, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy for H. pylori Diagnostics and Treatment in Adults
Authors:
- V. T. IvashkinVIV. T. Ivashkin
- T. L. LapinaTLT. L. Lapina
- I. V. MaevIMI. V. Maev
- R. S. KozlovR. S. Kozlov
- A. A. SheptulinASA. A. Sheptulin
- A. S. TrukhmanovATA. S. Trukhmanov
- S. R. AbdulkhakovSAS. R. Abdulkhakov
- O. P. AlekseevaOAO. P. Alekseeva
- S. A. AlekseenkoSAS. A. Alekseenko
- D. N. AndreevDAD. N. Andreev
- D. S. BordinD. S. Bordin
Open Access
- 30 December 2022
- journal article
- research article
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 32 (6) , 72-93
Abstract
Aim: bring to the attention of practitioners indications for anti-Helicobacter therapy, methods and procedure for diagnostics and eradication therapy ofН. pyloriinfection.Key points. Chronic gastritis caused byН. pyloriinfection, including asymptomatic persons, may be considered as an indication for eradication therapy of Н. pylori as etiological therapy and opportunistic screening for gastric cancer prevention. Indications, for obligatory anti-Helicobacter therapy include peptic ulcer, gastric MALT lymphoma, early gastric cancer (EGC) with endoscopic resection. H. pylori primary diagnostics methods include13C-urea breath test,H. pyloristool antigen lab test, rapid urease test and serological method. The serological method cannot be used after anti-Helicobacter therapy.In RussiaH. pyloristrains' resistance to clarithromycin does not exceed 15 % in most regional studies. The first line therapy forН. pyloriinfection eradication is the standard triple therapy including a proton pump inhibitor (PPI), clarithromycin and amoxicillin, enhanced with bismuthate tripotassium dicitrate. A classic four-component therapy based on bismuthate tripotassium dicitrate or quadrotherapy without bismuth drug products which includes PPI, amoxicillin, clarithromycin and metronidazole, may be used as alternative to the first line eradication therapy. The standard triple therapy may be prescribed for 14 days only in those regions, where it has been proven to be effective. Quadrotherapy with bismuthate tripotassium dicitrate is also used as main second line therapy in case of standard triple therapy, bismuth enhanced standard triple therapy or combined therapy failure. Another second line therapy includes PPI, levofloxacin and amoxicillin, to which a bismuth-containing drug product may be added. The third line therapy is selected individually based on previously used treatment settings.Conclusion. In each case ofH. pyloriinfection the decision for eradication therapy should be made, which is especially relevant as eradication ofH. pylorihas been recognized as an effective measure for the prevention of gastric cancer.Keywords
This publication has 97 references indexed in Scilit:
- Bismuth-containing quadruple therapy for Helicobacter pyloriEuropean Journal of Gastroenterology & Hepatology, 2013
- Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical TrialsPLOS ONE, 2013
- Additional corpus biopsy enhances the detection of Helicobacter pylori infection in a background of gastritis with atrophyBMC Gastroenterology, 2012
- Comparing Multiplex PCR and Rapid Urease Test in the Detection ofH. pyloriin Patients on Proton Pump InhibitorsGastroenterology Research and Practice, 2012
- Fifteen-Year Effects of Helicobacter pylori, Garlic, and Vitamin Treatments on Gastric Cancer Incidence and MortalityJNCI: Journal of the National Cancer Institute, 2012
- Meta‐analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatmentAlimentary Pharmacology & Therapeutics, 2010
- Dual specimens increase the diagnostic accuracy and reduce the reaction duration of rapid urease testWorld Journal of Gastroenterology, 2010
- Meta‐analysis: high‐dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradicationAlimentary Pharmacology & Therapeutics, 2008
- Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews, 2006
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000